Drug Profile
Research programme: neuropilin inhibitors - Helsinn International Services/Scientific Centre of Monaco
Latest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Helsinn International Services; Scientific Centre of Monaco
- Class Antineoplastics
- Mechanism of Action Neuropilin inhibitors; Neuropilin-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Renal cell carcinoma